|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.905 USD | +5.25% |
|
-5.84% | -20.77% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 91.68M 80.28M 74.11M 69.21M 130M 8.67B 133M 892M 344M 4.28B 344M 337M 14.85B | P/E 2026 * |
1.15x | P/E 2027 * | 5.47x |
|---|---|---|---|---|---|
| Enterprise Value | 91.68M 80.28M 74.11M 69.21M 130M 8.67B 133M 892M 344M 4.28B 344M 337M 14.85B | EV / Sales 2026 * |
1.15x | EV / Sales 2027 * | 0.68x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +5.25% | ||
| 1 week | -5.84% | ||
| Current month | +3.57% | ||
| 1 month | +3.57% | ||
| 3 months | +7.41% | ||
| 6 months | -18.99% | ||
| Current year | -20.77% |
| 1 week | 2.7 |  | 3.35 |
| 1 month | 2.53 | | 3.35 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.75 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 19/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 21/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 30/11/2008 |
| Chairman | 71 | 19/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 31/05/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-21 | Free | Chief Financial Officer | 400,000 | 1.2041% | ||
| 03-31 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-17 | Free | Chief Executive Officer | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.25% | -5.84% | +55.91% | -66.08% | 91.68M | |
| -0.45% | +2.77% | +19.90% | -11.14% | 64.39B | |
| +1.93% | +6.42% | +57.83% | +229.54% | 56.12B | |
| +7.82% | +44.80% | +44.80% | +44.80% | 40.54B | |
| +0.45% | -0.80% | -50.76% | -58.54% | 37.98B | |
| -0.06% | +7.76% | +71.35% | -23.72% | 31.89B | |
| +2.20% | +15.17% | +147.72% | -44.03% | 26.69B | |
| +0.37% | +9.99% | +67.43% | +84.35% | 22.73B | |
| +6.52% | +5.12% | +3.49% | +174.61% | 16.66B | |
| -0.77% | +4.00% | +60.51% | +123.05% | 16.6B | |
| Average | +2.33% | +4.76% | +47.82% | +45.28% | 31.37B | |
| Weighted average by Cap. | +1.84% | +5.86% | +42.19% | +53.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 69.94M 64.57M 60.29M 113M 7.55B 116M 777M 300M 3.73B 300M 293M 12.93B | 134M 117M 108M 101M 191M 12.68B 195M 1.3B 504M 6.26B 504M 493M 21.72B |
| Net income | 90.51M 79.25M 73.16M 68.32M 129M 8.56B 132M 880M 340M 4.22B 340M 332M 14.66B | 21.13M 18.5M 17.08M 15.95M 30.03M 2B 30.71M 206M 79.35M 986M 79.36M 77.61M 3.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | US$2.900 | +5.07% | 456,649 |
| 26/06/26 | US$2.760 | -8.61% | 1,103,740 |
| 25/06/26 | US$3.020 | -3.82% | 574,922 |
| 24/06/26 | US$3.140 | -0.63% | 898,517 |
| 23/06/26 | US$3.160 | +2.60% | 791,591 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
